Psychedelics Trials and Outcomes- A Closer Look.
JAMA Psychiatry July 15, 2026 DOI: 10.1001/jamapsychiatry.2026.1942 via PubMed
Summary
AI-generated from the abstractThis commentary examines the design and interpretation of clinical trials involving psychedelics, highlighting methodological challenges such as blinding, expectancy effects, and the influence of the therapeutic setting on outcomes. It argues that these factors complicate the attribution of therapeutic benefits solely to the drug itself and calls for more rigorous and nuanced approaches in future research.
Study at a glance
| Characteristics | Commentary Peer reviewed |
|---|---|
| Key finding | Methodological issues in psychedelic trials, including blinding and expectancy, make it difficult to attribute outcomes solely to the drug. |
Abstract
Psychedelics Trials and Outcomes- A Closer Look.